Andrea Apolo
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Andrea Apolo
Apr 1, 2024, 19:03 |
Blog
Top Influencers in GU Ocology by LARVOL
LARVOL shared on their X/Twitter page: "Delving into GU Oncology, we’re thrilled to spotlight the…
Jan 29, 2024, 14:47 |
Blog
Roberto Iacovelli: Andrea Apolo at GU24 presented results of AMBASSADOR trial
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…
Oct 27, 2023, 04:48 |
Insight
Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901
Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter: "Eloquent…
Oct 24, 2023, 14:57 |
Blog
ESMO updates from Presidential Symposium- European Society for Medical Oncology (ESMO)
European Society for Medical Oncology (ESMO) shared on LinkedIn: "Positive outcomes in advanced or metastatic…
Oct 1, 2023, 12:45 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 6
In August, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion Leaders…
Aug 6, 2023, 18:56 |
Blog
Why do we come to BCANTT? - Andrea Apolo
Why do we come to BCANTT? To get inspired by patients and amazing colleagues! To…
All:
6
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube